Original Text: |
    Any concurrent active malignancies, defined as malignancies requiring any therapy other than expectant observation, because adverse events (AEs) resulting from these malignancies or their treatment may confound our assessment of the safety of adoptive T-cell therapy for ovarian cancer
Disease/Condition: Concurrent Active Malignancy, Active Malignancy
Procedure: none
Drug: none
Biomarker: none
Computable Rule: |
    MALIGNANCY == True, ACTIVE == True
